Comerica Bank
RXII

Comerica Bank’s GALENA BIOPHARMA INC COM RXII Stock Holding History

Comerica Bank’s Portfolio RXII Stock Details RXII Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-11,500
Closed -$4K – 2227
2016
Q3 		$4K Sell
11,500
-102
-0.9% -$35 ﹤0.01% 2099
2016
Q2 		$5K Hold
11,602
– – ﹤0.01% 2088
2016
Q1 		$18K Hold
11,602
– – ﹤0.01% 2080
2015
Q4 		$9K Sell
11,602
-499
-4% -$387 ﹤0.01% 2067
2015
Q3 		$19K Sell
12,101
-12,101
-50% -$19K ﹤0.01% 2040
2015
Q2 		$42K Buy
+24,202
New +$42K ﹤0.01% 2063

Comerica Bank's RXII Position: Q4 2016 in Review

Comerica Bank sold out of GALENA BIOPHARMA INC COM (RXII) in Q4 2016, closing a stake of 11,500 shares — an estimated $4K sold.

Comerica Bank first reported a position in RXII in Q2 2015 and held it in 6 quarters. The position peaked at $42K in Q2 2015. 0 funds tracked by Wall St. Rank hold RXII as of Q4 2016.

  • Comerica Bank reported no remaining GALENA BIOPHARMA INC COM position as of Q4 2016 after selling out during the quarter.
  • Comerica Bank sold 11,500 GALENA BIOPHARMA INC COM shares in Q4 2016, an estimated $4K.
  • Comerica Bank first reported a position in GALENA BIOPHARMA INC COM in Q2 2015 and held it in 6 quarters.
  • Comerica Bank's GALENA BIOPHARMA INC COM position peaked at $42K in Q2 2015.
  • 0 funds tracked by Wall St. Rank held GALENA BIOPHARMA INC COM as of Q4 2016.

Based on Comerica Bank's 13F filing for Q4 2016, filed 8 Feb 2017.